Sequences
Sequences for oat
Oat sequences has been published and are available from this site.
Sequences for wheat and barley
Terms and Conditions of Use of DArT marker sequences
The DNA sequence of the 2,000 DArT markers from wheat and 2,000 DArT markers for barley which were developed with financial support from Grains Research and Development Corporation (GRDC) of Australia and a number of other funding organisations are made available by: Diversity Arrays Technology Pty Ltd (Australian Company Number 097 662 514) and its wholly-owned subsidiary Triticarte Pty Ltd (Australian Company Number 105 494 522), both of 1 Wilf Crane Crescent, Yarralumla ACT 2600, AUSTRALIA (hereinafter "The Providers"), to any person requesting sequences (hereinafter "Recipient") under the following Terms and Conditions:
- The Providers claim Copyright on the complete set, or any significant subset, of the sequences made available to the public.
- The Providers make available the sequences to Recipient WITH NO WARRANTY OF ACCURACY, USEFULNESS AND FREEDOM TO USE.
- Recipient cannot use any DArT marker sequence (hereinafter "Sequence") or any part of Sequence to provide genotyping services to third parties. Recipient can use Sequence in-house for any research and development activities, including plant breeding and commercial product development.
- Recipient must not distribute Sequence or any part of Sequence to any other person or organization, except those scientists affiliated with and working within the Recipient's institution in collaboration with the Recipient, who have agreed to the Terms and Conditions.
- Recipient must acknowledge the source of Sequence in scientific papers, publications and reports by providing a link to the page (http://www.diversityarrays.com/sequences.html)
- Recipient must identify any new molecular marker derived from Sequence as "derived from DArT marker (MarkerName)" in all scientific papers, publications and reports.
- Recipient accepts to bear ALL responsibility for any consequence of the use of Sequence, including any claim by a third party that the use of Sequence infringes any intellectual property right.
